Efficacy of innovative therapies in myasthenia gravis: A systematic review, meta‐analysis and network meta‐analysis

Citations Over TimeTop 1% of 2023 papers

Abstract

Anti-complement and FcRn treatments both proved to be effective in MG patients, whereas rituximab did not show a significant benefit for patients. Within the limitations of this meta-analysis, including efficacy time points, FcRn treatments showed a greater effect on QMG score in the short term. Real-life studies with long-term measurements are needed to confirm our results.

Related Papers

• → Two cases of thymoma-associated myasthenia gravis without antibodies to the acetylcholine receptor(2008)29 cited
• → Myasthénie séro-négative(2004)10 cited
• [Myasthenia gravis (1). Experimental myasthenia gravis--a tool for the study of the pathogenesis, diagnosis and treatment of myasthenia gravis].(1978)